Abstract
Gene therapy could potentially revolutionize the treatment of gastrointestinal (GI) tract cancer. The aim of this study was to establish a practical method of gene transfer which would be applicable to human gastric cancer. Retrovirus or/and adenovirus vectors carrying the lacZ marker gene were transferred in situ by needle through an endoscopic biopsy channel into primary gastric cancer in six male beagle dogs that had been treated with N‐ethyl‐N′‐nitro‐N‐nitrosoguanidine (ENNG). In addition, an adenovirus vector carrying the herpes simplex virus thymidine kinase (Ad.CAGHSV‐TK) gene was introduced in situ into cancer tissues in the stomach of three dog, and the animals were treated with intravenous ganciclovir (GCV). Retrovirus‐producing cells which expressed the lacZ gene were specifically localized to the injection site in the stomach. The lacZ gene was more widely transferred into the tumor by the adenovirus vector than by retrovirus‐producing cells. Improvement of the needle used for gene transfer and the use of multiple injections per tumor led to more diffuse transfer of the vector into the tumor. The Ad.CAG lacZ gene was also transferred into regional lymph nodes of the stomach. Moderate to diffuse degeneration of the primary cancer tissues of the stomach was found after Ad.CAGHSV‐TK/GCV gene therapy. Moreover, almost complete tissue degeneration was observed in the regional lymph nodes of the stomach. An adverse effect of HSV‐TK/GCV gene therapy was acute hepatotoxicity, which was not found after Ad.CAG lacZ gene transfer, but was found after high‐titer Ad.CAGHSV‐TK gene transfer followed by GCV. These findings suggest that in situ gene transfer of a suicide gene followed by prodrug treatment may be applicable not only to primary tumors, but also to lymph node metastases of gastric cancer, though further study of both beneficial and adverse effects is required before clinical usage.
Keywords: Gene therapy, Suicide gene, Adenovirus vector, Lymph node, Dog
Full Text
The Full Text of this article is available as a PDF (7.1 MB).
REFERENCES
- 1).Anderson , W. F.Human gene therapy . Science , 256 , 808 – 813 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 2).Miller , A. D.Human gene therapy comes of age . Nature , 357 , 455 – 460 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 3).Anderson , W. F.Gene therapy for cancer . Hum. Gene Ther. , 5 , 1 – 2 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 4).Mastrangelo , M. , Berd , D. , Nathan , F. E. and Lattime , E. C.Gene therapy for human cancer: an essay for clinicians . Semin. Oncol. , 23 , 4 – 21 ( 1996. ). [PubMed] [Google Scholar]
- 5).Fearson , E. R. and Vogelstein , B.A genetic model for colorectal tumorigenesis . Cell , 61 , 759 – 767 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 6).Harris , C. C.Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies . J. Natl. Cancer Inst. , 88 , 1442 – 1455 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 7).Freeman , S. M. , Whartenby , K. A. , Freeman , J. L. , Abboud , C. N. and Marrogi , A. J.In situ use of suicide genes for cancer therapy . Semin. Oncol. , 23 , 31 – 45 ( 1996. ). [PubMed] [Google Scholar]
- 8).Tanaka , T. , Kanai , F. , Okabe , S. , Yoshida , Y. , Wakimoto , H. , Hamada , H. , Shiratori , Y. , Lan , K.‐H. , Isitobi , M. and Omata , M.Adenovirus‐mediated prodrug gene therapy for carcinoembryonic antigen‐producing human gastric carcinoma cells in vitro . Cancer Res. , 56 , 1341 – 1345 ( 1996. ). [PubMed] [Google Scholar]
- 9).Tanaka , T. , Kanai , F. , Lan , K.‐H. , Ohashi , M. , Shiratori , Y. , Yoshida , Y. , Hamada , H. and Omata , M.Adenovirus‐mediated gene therapy of gastric carcinoma using cancer‐specific gene expression in vivo . Biochem. Biophys. Res. Commun. , 231 , 775 – 779 ( 1997. ). [DOI] [PubMed] [Google Scholar]
- 10).Freeman , S. M. , Abboud , C. N. , Whartenby , K. A. , Packman , C. H. , Koeplin , D. S. , Moolten , F. L. and Abraham , G. N.The “bystander effect”: tumor regression when a fraction of the tumor mass is genetically modified . Cancer Res. , 53 , 5274 – 5283 ( 1993. ). [PubMed] [Google Scholar]
- 11).Yamamoto , S. , Suzuki , S. , Hoshino , A. , Akimoto , M. and Shimada , T.Herpes simplex virus thymidine kinase/ganciclovir‐mediated killing of tumor cell induced tumor‐specific cytotoxic T cells in mice . Cancer Gene Ther. , 4 , 91 – 96 ( 1997. ). [PubMed] [Google Scholar]
- 12).Harris , J. D. , Gutierrez , A. A. , Hurst , H. C. , Sikora , K. and Lemoine , N. R.Gene therapy for cancer using tumor‐specific prodrug activation . Gene Ther. , 1 , 170 – 175 ( 1994. ). [PubMed] [Google Scholar]
- 13).Sasajima , K. , Kawachi , T. , Sano , T. , Sugimura , T. , Shimozato , Y. and Shirota , A.Esophageal and gastric cancers with metastases induced in dogs by N‐ethyl‐N′‐nitro‐N‐nitrosoguanidine . J. Natl. Cancer Inst. , 58 , 1789 – 1794 ( 1977. ). [DOI] [PubMed] [Google Scholar]
- 14).Kurihara , M.Inducement of canine gastric cancer by N‐ethyl‐N′‐nitro‐N‐nitrosoguanidine (ENNG) . Gastric Cancer , 1 , 95 – 103 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 15).Kotani , H. , Newton , P. B. , III , Zhang , S. , Chiang , Y. L. , Otto , E. , Weaver , L. , Blaese , R. M. , Anderson , W. F. and McGarrity , G. J.Improved methods of retroviral vector transduction and production for gene therapy . Hum. Gene Ther. , 5 , 19 – 28 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 16).Miyake , S. , Makimura , M. , Kanegae , Y. , Harada , S. , Sato , Y. , Takamori , K. , Tokuda , C. and Saito , I.Efficient generation of recombinant adenoviruses using adenovirus DNA‐terminal protein complex and a cosmid bearing the full‐length virus genome . Proc. Natl. Acad. Sci. USA , 93 , 1320 – 1324 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17).Kanegae , Y. , Makimura , M. and Saito , I.A simple and efficient method for purification of infectious recombinant adenovirus . Jpn. J. Med. Sci. Biol. , 47 , 157 – 166 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 18).Sambrook , J. , Fritsch , E. F. and Maniatis , T. “ Molecular Cloning, a Laboratory Manual ” 2nd Ed. ( 1989. ). Plainview, Cold Spring Harbor Laboratory; , NY . [Google Scholar]
- 19).Japanese Research Society for Gastric Cancer . “ Japanese Classification of Gastric Carcinoma ” English Ed. ( 1995. ). Kanehara & Co., Ltd. , Tokyo . [Google Scholar]
- 20).Roth , J. A. , Nguyen , D. , Lawrence , D. D. , Kemp , B. L. , Carrasco , C. H. , Ferson , D. Z. , Hong , W. K. , Komaki , R. , Lee , J. J. , Nesbitt , J. C. , Pisters , K. M. , Putnam , J. B. , Schea , R. , Shin , D. M. , Walsh , G. L. , Dolormente , M. M. , Han , C. I. , Martin , F. D. , Yen , N. , Xu , K. , Stephens , L. C. , McDonnell , T. J. , Mukhopadhyay , T. and Cai , D.Retrovirus‐mediated wild‐type p53 gene transfer to tumors of patients with lung cancer . Nat. Med. , 2 , 985 – 991 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 21).Blasé , M. , Blankenstein , T. , Brenner , M. , Cohen–Haguenauer , O. , Gansbacher , B. , Russell , S. , Sorrentino , B. and Velu , T.Vectors in cancer therapy: how will they deliver ? Cancer Gene Ther. , 2 , 291 , 297 – 1995. . [PubMed] [Google Scholar]
- 22).Brand , K. , Arnold , W. , Bartels , T. , Lieber , A. , Kay , M. A. , Strauss , M. and Dorken , B.Liver‐associated toxicity of the HSV‐tk/GCV approach and adenovirus vectors . Cancer Gene Ther. , 4 , 9 – 16 ( 1997. ). [PubMed] [Google Scholar]
- 23).van der Eb , M. M. , Cramer , S. J. , Vergouwe , Y. , Schagen , F. H. E. , van Krieken , J. H. J. M. , van der Eb , A. J. , Borel Rinkes , I. H. M. , van der Velde , C. J. H. and Hoeben , R. C.Severe hepatic dysfunction after adenovirus‐mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration . Gene Ther. , 5 , 451 – 458 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 24).Lan , K. H. , Kanai , F. , Shiratori , Y. , Okabe , S. , Yoshida , Y. , Wakimoto , H. , Hamada , H. , Tanaka , T. , Ohashi , M. and Omata , M.Tumor‐specific gene expression in carcinoembryonic antigen‐producing gastric cancer cells using adenovirus vectors . Gastroenterology , 111 , 1241 – 1251 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 25).Onda , M. and Matsukura , N.Gene therapy for gastrointestinal tract cancer: prospects for combination treatment consisting of surgery and molecular surgery . Surg. Today , 27 , 1099 – 1102 ( 1997. ). [Google Scholar]